Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
Author:
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference86 articles.
1. Chimeric antigen receptor-modified T-cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013
2. Chimeric antigen receptor-redirected CD45RA-negative T-cells have potent antileukemia and pathogen memory response without graft-versus-host activity;Chan;Leukemia,2015
3. Murine allogeneic CD19 CAR T-cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD;Jacoby;Blood,2016
4. T-cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci Transl Med,2011
5. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T-cells;Kebriaei;J Clin Invest,2016
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12
2. Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances;Life Sciences;2024-06
3. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy;Cancers;2024-05-24
4. Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?;Life;2023-09-18
5. A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma;Vaccines;2023-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3